122 related articles for article (PubMed ID: 11351251)
21. Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells.
Okamoto T; Yamada N; Tsujimura T; Sugihara A; Nishizawa Y; Ueda H; Kashiwamura S; Tsutsui H; Futani H; Maruo S; Okamura H; Terada N
J Interferon Cytokine Res; 2004 Mar; 24(3):161-7. PubMed ID: 15035849
[TBL] [Abstract][Full Text] [Related]
22. A murine osteosarcoma cell line with a potential to develop ossification upon transplantation.
Kusumi T; Nishi T; Tanaka M; Tsuchida S; Kudo H
Jpn J Cancer Res; 2001 Jun; 92(6):649-58. PubMed ID: 11429054
[TBL] [Abstract][Full Text] [Related]
23. Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.
Kim JL; Park SH; Jeong D; Nam JS; Kang YH
Exp Biol Med (Maywood); 2012 Apr; 237(4):417-28. PubMed ID: 22496431
[TBL] [Abstract][Full Text] [Related]
24. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line.
Asai T; Tomita Y; Nakatsuka S; Hoshida Y; Myoui A; Yoshikawa H; Aozasa K
Jpn J Cancer Res; 2002 Mar; 93(3):296-304. PubMed ID: 11927012
[TBL] [Abstract][Full Text] [Related]
25. Mineralization of matrix vesicles isolated from a human osteosarcoma cell line in culture with water-soluble chitosan-containing medium.
Yamada S; Ohara N; Hayashi Y
J Biomed Mater Res A; 2003 Sep; 66(3):500-6. PubMed ID: 12918032
[TBL] [Abstract][Full Text] [Related]
26. [Effect of fluo-hydroxyapatite on biological properies of osteosarcoma MG63 cells].
Liu H; Guo X; Liu X; Chen W; Zhao N; Liao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jan; 50(1):38-42. PubMed ID: 25779074
[TBL] [Abstract][Full Text] [Related]
27. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
[TBL] [Abstract][Full Text] [Related]
29. Developmental pathways hijacked by osteosarcoma.
Mortus JR; Zhang Y; Hughes DP
Adv Exp Med Biol; 2014; 804():93-118. PubMed ID: 24924170
[TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
[TBL] [Abstract][Full Text] [Related]
31. Sex steroids and bone metabolism: comparison of in vitro effects of 17beta-estradiol and testosterone on human osteosarcoma cell lines of various gender and differentiation.
Fohr B; Schulz A; Battmann A
Exp Clin Endocrinol Diabetes; 2000; 108(6):414-23. PubMed ID: 11026755
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
33. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
34. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma.
Arihiro K; Inai K
Pathol Int; 2001 Feb; 51(2):100-6. PubMed ID: 11169148
[TBL] [Abstract][Full Text] [Related]
36. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages.
Chen D; Ji X; Harris MA; Feng JQ; Karsenty G; Celeste AJ; Rosen V; Mundy GR; Harris SE
J Cell Biol; 1998 Jul; 142(1):295-305. PubMed ID: 9660882
[TBL] [Abstract][Full Text] [Related]
37. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung.
Asai T; Ueda T; Itoh K; Yoshioka K; Aoki Y; Mori S; Yoshikawa H
Int J Cancer; 1998 May; 76(3):418-22. PubMed ID: 9579581
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells.
Huang W; Rudkin GH; Carlsen B; Ishida K; Ghasri P; Anvar B; Yamaguchi DT; Miller TA
Exp Cell Res; 2002 Apr; 274(2):226-34. PubMed ID: 11900483
[TBL] [Abstract][Full Text] [Related]
40. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production.
Chang JK; Hsu YL; Teng IC; Kuo PL
Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
